SCHEMBL17799696

SCHEMBL17799696

O=C(N[C@H]1CC[C@H]1c1ccc(F)cc1F)c1sccc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ GSK3A P49840 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ FPR1 P21462 3/20 0.35
▸ FPR2 P25090 2/20 0.35
▸ TAS1R3 Q7RTX0 1/20 0.35
▸ TAS1R1 Q7RTX1 1/20 0.35
▸ TAS1R2 Q8TE23 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HTR2A P28223 2/20 0.34
▸ HCRTR1 O43613 2/20 0.34
▸ MC1R Q01726 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17799753 0.87 F10 (0.39) ALDH1A1KDM4EGAAMEN1CYP1A2
SCHEMBL17799747 0.85 TAS1R3 (0.39) FPR1FPR2TAS1R3TAS1R1TAS1R2
SCHEMBL17799691 0.81 TSHR (0.56) ALDH1A1KDM4EGAAMEN1CYP1A2
SCHEMBL17799701 0.81 TAS1R3 (0.39) FPR1FPR2TAS1R3TAS1R1TAS1R2
SCHEMBL17799722 0.81 HPGD (0.41) FPR1FPR2TAS1R3TAS1R1TAS1R2
SCHEMBL17799748 0.80 NPC1 (0.44) ALDH1A1KMT2ATAS1R3TAS1R1TAS1R2
SCHEMBL17799697 0.79 NPC1 (0.40) ALDH1A1GAAMEN1CYP2C9KMT2A
SCHEMBL20298551 0.78 MC1R (0.37) KMT2AFPR1FPR2RAB9AHCRTR1
SCHEMBL17799700 0.78 HCRTR1 (0.49) GAAKMT2AFPR1FPR2TAS1R3
SCHEMBL20298654 0.77 MC1R (0.35) FPR1FPR2TAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
EP-3019476-B1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-01-17 — — EP disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS ALDH1A1 1093/4885KDM4E 325/4885GAA 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback